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In cystic fibrosis (CF) airways, abnormal epithelial
ion transport likely initiates mucus stasis, resulting in
persistent airway infections and chronic inflammation.
Mucus clearance is regulated, in part, by activation of
apical membrane receptors coupled to intracellular cal-
cium (Ca2i) mobilization. We have shown that Ca
2
i
signals resulting from apical purinoceptor (P2Y2-R) ac-
tivation are increased in CF compared with normal hu-
man airway epithelia. The present study addressed the
mechanism for the larger apical P2Y2-R-dependent
Ca2i signals in CF human airway epithelia. We show
that the increased Ca2i mobilization in CF was not
specific to P2Y2-Rs because it was mimicked by apical
bradykinin receptor activation, and it did not result
from a greater number of P2Y2-R or a more efficient
coupling between P2Y2-Rs and phospholipase C-gener-
ated inositol 1,4,5-trisphosphate. Rather, the larger api-
cal P2Y2-R activation-promoted Ca
2
i signals in CF epi-
thelia resulted from an increased density and Ca2
storage capacity of apically confined endoplasmic retic-
ulum (ER) Ca2 stores. To address whether the ER up-
regulation resulted from ER retention of misfolded
F508 CFTR or was an acquired response to chronic
luminal airway infection/inflammation, three ap-
proaches were used. First, ER density was studied in
normal and CF sweat duct human epithelia expressing
high levels of F508 CFTR, and it was found to be the
same in normal and CF epithelia. Second, apical ER
density was morphometrically analyzed in airway epi-
thelia from normal subjects, F508 homozygous CF pa-
tients, and a disease control, primary ciliary dyskinesia;
it was found to be greater in both CF and primary ciliary
dyskinesia. Third, apical ER density and P2Y2-R activa-
tion-mobilized Ca2i, which were investigated in airway
epithelia in a long term culture in the absence of luminal
infection, were similar in normal and CF epithelia. To
directly test whether luminal infection/inflammation
triggers an up-regulation of the apically confined ER
Ca2 stores, normal airway epithelia were chronically
exposed to supernatant from mucopurulent material
from CF airways. Supernatant treatment expanded the
apically confined ER, resulting in larger apical P2Y2-R
activation-dependent Ca2i responses, which repro-
duced the increased Ca2i signals observed in CF epi-
thelia. In conclusion, the mechanism for the larger Ca2i
signals elicited by apical P2Y2-R activation in CF airway
epithelia is an expansion of the apical ER Ca2 stores
triggered by chronic luminal airway infection/inflam-
mation. Greater ER-derived Ca2i signals may provide a
compensatory mechanism to restore, at least acutely,
mucus clearance in CF airways.
Airway epithelia constitute the major interface between in-
spired air and the airway wall. These epithelia are highly
polarized and exhibit a series of integrated functions that pro-
vide mechanical cleansing, i.e. mucus clearance, as a primary
mode of lung defense. The individual airway epithelial func-
tional components that mediate mucus clearance, including ion
transport, mucin secretion, and ciliary beat frequency (1), are
regulated in part by intracellular calcium (Ca2i) (2, 3). Airway
epithelial Ca2i mobilization can be elicited by selective auto-
crine and/or paracrine activation of apical or basolateral mem-
brane heterotrimeric G protein-coupled receptors (GPCRs)1
linked to phospholipase C (PLC) stimulation, which generates
inositol 1,4,5-trisphosphate (IP3) and induces Ca
2 release
from endoplasmic reticulum (ER) stores (3, 4). 5 nucleotides
(ATP/UTP), released by airway epithelial cells and sensed by
apical membrane purinoceptors (P2Y2-Rs) (5), may be the dom-
inant autocrine regulators of Ca2i mobilization in airway
epithelia (3).
In airway epithelia of patients with cystic fibrosis (CF), the
functional absence of the cystic fibrosis transmembrane con-
ductance regulator (CFTR) results in a diminished periciliary
liquid layer depth (6) and a reduction in mucus clearance.
Likewise, abnormal mucus clearance is found in patients with
primary ciliary dyskinesia (PCD), a syndrome that results from
defective airway epithelial ciliary proteins linked to a de-
creased ciliary activity (7). In both diseases, persistent airways
infection and inflammation are the predominant clinical phe-
notypic characteristics consequent to the impairment of mucus
clearance (8).
There are clues that airway epithelia may regulate the Ca2i
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signaling pathway in response to airways disease. For example,
in vivo studies established that the nasal transepithelial elec-
trical potential difference responses to agents that activate
P2Y2-Rs and promote Ca
2
i mobilization (e.g. ATP/UTP) are
greater in CF patients than in normal subjects (9, 10). In vitro
studies also detected a larger apical Ca2i-dependent Cl
 con-
ductance in CF airway epithelia (9, 11–13). In addition, we
recently reported that apical P2Y2-R activation promotes
greater Ca2i mobilization in CF compared with normal human
nasal epithelia (4). However, the underlying mechanism(s) re-
sponsible for the regulation of the increased Ca2i responsive-
ness of CF airway epithelia and its functional consequences
are unknown.
Therefore, in the present study we investigated the mecha-
nism for the augmented apical GPCR-derived Ca2i signals in
CF airway epithelia by probing the P2Y2-R/Ca
2 signaling
system in functional, biochemical, and cell biological studies in
normal and CF human airway epithelia. Further, we investi-
gated whether the raised Ca2i signals in CF are a manifesta-
tion of the molecular pathogenesis of mutant CFTR (F508
CFTR) or are an acquired host response to chronic infection/
inflammation in vivo. We compared ER density in non-infected
human sweat duct epithelia from normal and F508 CF indi-
viduals and in human airway epithelia from normal, F508
CF, and PCD patients with chronic airway infection and in-
flammation. In addition, ER density and apical P2Y2-R activa-
tion-induced Ca2i mobilization were studied in short term and
long term cultures of normal and CF bronchial epithelia. Fi-
nally, to directly address whether chronic airway infection/
inflammation, independently of defective CFTR, up-regulated
apically confined ER Ca2 stores, ER density and UTP-mobi-
lized ER Ca2 were investigated in normal airway epithelia
chronically exposed to supernatant from CF airways mucopu-
rulent material (SMM).
EXPERIMENTAL PROCEDURES
Cell Culture and Freshly Excised Tissue—Tissues and cells were
obtained under the auspices of protocols approved by the Institutional
Committee on the Protection of the Rights of Human Subjects. Excess
tissues from human donor lungs and excised recipient lungs were
obtained at the time of lung transplantation from main stem or lobar
bronchi. Tissues were either fixed in 4% paraformaldehyde and embed-
ded in paraffin or used for cell isolation. Bronchial epithelial cells were
provided by the University of North Carolina CF Center Tissue Core.
Normal and CF (F508 homozygous) cells were harvested and cultured
as described previously (4). Cultures were maintained at an air-liquid
surface interface, and polarized primary cultures were studied at 6–11
days (short term monolayers) or 30–40 days later (long term well
differentiated). Normal and CF cultures were apically washed with
sterile PBS, and the serosal media were replenished every 2–4 days.
Nasal scrapes obtained from normal (n  4, ages 33–35), F508
homozygous CF (n  4, ages 25–46), or PCD (n  3, ages 34–57)
individuals and skin biopsies from normal (n  4, ages 28–47) and
F508 homozygous CF (n  5, ages 31–47) individuals were used for
ER density studies.
Ca2i Studies—6–11- or 30–40-day-old cultures were loaded with
fura-2/AM, and Ca2i was measured under bilateral perfusion as re-
ported previously (4). Ca2i signals were calibrated as described previ-
ously (14). There were no systematic differences between CF and nor-
mal epithelia as a result of differential fura-2 behavior, including dye
loading. Baseline Ca2i levels were the same in CF and normal epithe-
lia, as reported previously (4), and no consistent differences were ob-
served between CF and normal epithelia in the sustained phase of Ca2i
mobilization following activation of P2Y2-Rs.
Ribonuclease Protection Assay (RPA)—A 398-base pair human
P2Y2-R fragment was prepared by reverse transcriptase-PCR from
human airway RNA and ligated into the pCRII vector (Invitrogen).
P2Y2-R primer sequences were as follows: 253F, 5AGACCTGGGCCC-
CTGGAATGACACCATC3; and 651R, 5AGACGCCCAGACACC-
GGTGCACGCTGATG3.
Individual clones were verified by automatic sequencing. Templates
for RPAs were prepared by PCR from the P2Y2-R plasmid with the
following primers for the PCRII vector: PCRII SP6, 5ATGATTACGC-
CAAGCTATTTAGGTGACACT3 and PCRII T7, 5GACGGCCAGTG-
AATTGTAATACGACTCACT3.
50 ng of purified PCR fragment was transcribed, incorporating the
[32P]UTP label with the Maxiscript kit (Ambion), and RPA was performed
with the RPA III kit (Ambion). Protected fragments were quantified by
phosphorimaging with ImageQuant software (Amersham Biosciences).
Phospholipase C Activity—After 4 days in culture, monolayers of
normal and CF bronchial epithelia were radiolabeled with [3H]inositol
for 4–5 days (15). For 20 min prior to study, cultures were placed in
serum-free media containing 10 mM lithium and [3H]inositol followed
by 5 min 100 M mucosal UTP-induced PLC activity measured as
reported previously (15). The levels of 3H-labeled inositol phosphates
were normalized to [3H]IP6 levels because IP6 levels are not affected by
agonist stimulation (16). Assays were performed in duplicate.
Immunostaining of Calreticulin and IP3 receptors (IP3Rs) and
DIOC6(3) Staining—The immunostaining of calreticulin and IP3Rs in
cultures and deparaffinized native bronchial epithelial or skin biopsy
sections was performed according to a modification of our previous
method (17). For calreticulin and IP3Rs staining, samples were incu-
bated with a rabbit anti-calreticulin antibody (1:100 dilution, Affinity
Bioreagents) and a mouse anti-IP3R antibody that recognizes all IP3R
isoforms (1:100 dilution, Calbiochem) for 60 min at 37 °C. This incuba-
tion was followed by three PBS washes and a 30-min incubation at
25 °C with a fluorescein-labeled goat anti-rabbit antibody (1:20 dilution
for calreticulin, Kirkegaard & Perry Laboratories) and with a Texas
Red-labeled goat anti-mouse antibody (1:200 dilution for IP3Rs, Jackson
Immunoresearch Laboratories). As controls, the primary antibodies
were omitted or substituted with rabbit and mouse -globulins (Jackson
Immunoresearch Laboratories). For antibody-independent ER staining,
sections of native bronchial epithelia were labeled with the fluorescent
dihexaoxacarbocyanine dye DIOC6(3) by incubation with 250 ng/ml
DIOC6(3) for 1 min at room temperature in PBS followed by three
washes with PBS as we have reported previously (17). The Ca2 store
markers and the DIOC6(3) signals were studied by laser confocal mi-
croscopy (Leica, model TCS 4D, PL APO 63x/1.20 mm water lens) in the
XZ or XY scanning mode.
To quantify the fluorescence intensity of labeled calreticulin and
IP3Rs and DIOC6(3), multiple scans were obtained from each sample,
and regions of interest were designated in the apical domains with the
MetaMorph software. The same acquisition parameters (e.g. laser
power, contrast, brightness, and pinhole value) were employed for each
channel to acquire the images from normal and CF cultures or native
tissue in experiments performed on the same day. The fluorescence
intensity values from the regions of interest were averaged from paired
normal and CF cultures, native bronchial epithelia, skin biopsies, or
normal cultures treated with PBS or supernatant from CF airways
mucopurulent material (SMM, see “Studies with Infectious/Inflamma-
tory Material from CF Airways”).
Calreticulin Western Blot Analysis—Monolayers of normal and CF
bronchial epithelia were lysed and blotted as reported previously (18).
The calreticulin antibody was a rabbit polyclonal (1:5000 dilution, Af-
finity Bioreagents), and the secondary antibody was an anti-rabbit
horseradish peroxidase (1:10,000 dilution, Amersham Biosciences).
Blots were developed with enhanced chemiluminescence.
Electron Microscopy—Nasal scrapes from normal, F508 homozy-
gous CF, and PCD individuals were fixed in 2% glutaraldehyde plus 2%
paraformaldehyde plus 0.25% tannic acid, post-fixed in 1% OsO4, and
processed for electron microscopy (19). Apical ER morphometric scoring
was performed double blind. Only ciliated cells were analyzed, and
repairing cells with migrating basal bodies (procentrioles) and micro-
graphs with tangential cuts were excluded. The apical domain was
defined as the region 1–3.4 m (to exclude basal bodies) from the apical
plasma membrane. The criteria for identifying ER were: parallel mem-
branes in elongated or oval strands, containing an amorphous center
without cristae (to exclude mitochondria), or electron-dense particles (to
exclude rough ER, because it is increased in repairing cells), and not
stacked (to exclude Golgi). Data are expressed as number of ER
strands/m2.
Studies with Infectious/Inflammatory Material from CF Airways—
Mucopurulent material was harvested from the airway lumens of ex-
cised human CF lungs infected with Pseudomonas aeruginosa and S.
aureus at the time of transplant and provided by the University of
North Carolina CF Center Tissue Core. This material was centrifuged
at 100,000 rpm (60 min, 4 °C), and the supernatant was filtered through
a 0.2-m filter and frozen at 80 °C. Preliminary studies revealed that
treatment of airway epithelia with SMM from individual CF lungs
infected with P. aeruginosa and Staphyloccocus aureus induced epithe-
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lial hyperinflammation. Because of the small volume of SMM/patient,
SMMs from nine CF lungs (five males and four females, age 17–48
years, four F508 homozygous and five unknown genotypes) were
pooled to assure homogeneous stimulus throughout experiments.
To address the effect of SMM on ER size and Ca2 storage, PBS or
SMM (40 l) was applied to the mucosal surfaces of well differentiated
cultures of normal bronchial epithelia for 48 h, and then either ER volume
was studied by calreticulin immunostaining as described above or peak
Ca2i responses to 100 M mucosal UTP were measured, respectively.
Statistics—Data represent the mean  S.E. from at least three
experiments from three individual donors and were analyzed by un-
paired t test or two-way analysis of variance. Statistical significance
was defined with p  0.05.
RESULTS
Larger Apical GPCR-modulated Ca2i Responses Are a Gen-
eralized Feature of CF Airway Epithelia—We have shown pre-
viously that CF human nasal epithelia exhibit larger rises in
Ca2i in response to apical P2Y2-R activation than normal
nasal epithelia (4). To investigate whether this difference was
generalized to lower airways, we studied the effect of a maxi-
mal dose (100 M) UTP applied to the apical surface of 6–11-
day-old monolayers of normal and CF human bronchial epithe-
lial cultures on Ca2i mobilization (4). UTP addition to normal
bronchial epithelium induced an initial Ca2i peak, resulting
from IP3-dependent ER Ca
2 store release, and a sustained rise
in Ca2i, resulting from activation of capacitative Ca
2 entry
(3) (Fig. 1A). P2Y2-R activation in CF epithelium (Fig. 1B)
resulted in a markedly higher Ca2i mobilization peak than in
normal epithelium, in agreement with our findings in nasal
epithelia (4). Fig. 1C illustrates the summary Ca2i data
(peak-baseline Ca2i values) from these studies.
We next addressed whether the larger Ca2i mobilization in
CF was a specific property of P2Y2-R activation or was gener-
alized to other GPCRs linked to PLC at the apical membrane.
Fig. 1, D and E, shows representative Ca2i tracings from
6–11-day-old monolayers of normal and CF bronchial epithelial
cultures, respectively, following apical addition of a maximal
dose (5 M) of bradykinin. Fig. 1F depicts the summary Ca2i
data from these experiments, illustrating that apical bradyki-
nin receptor activation in CF also resulted in an increased
Ca2i mobilization. Because the greater bradykinin-induced
Ca2i signal in CF mimicked that elicited by P2Y2-R activation,
the larger Ca2i signal in CF does not depend on a specific
class of GPCRs.
P2Y2-R Number and P2Y2-R-dependent PLC Activation Are
the Same in Normal and CF Airway Epithelia—We tested
whether P2Y2-R expression was increased in CF. Because no
antibodies or radioligands were available for P2Y2-R quantifi-
cation, we used an RPA to assess P2Y2-R steady-state mRNA
levels in 6–11-day-old primary culture monolayers of normal
and CF bronchial airway epithelia. No difference was found in
P2Y2-R mRNA levels from normal compared with CF human
airway epithelia (Fig. 2, A and B).
We next investigated whether the larger Ca2i mobilization
in CF was driven by an enhanced PLC response to P2Y2-R
activation. P2Y2-R-regulated PLC activity was assayed by
measuring IP3 and the accumulation of its downstream metab-
olites in the presence of lithium to prevent recycling of inositol
phosphates back to inositol (20). We found that PLC activation
in response to a 5-min treatment with 100 M apical UTP was
not elevated in 6–11-day-old primary culture monolayers of CF
(Fig. 2C). These findings indicate that the larger Ca2i in CF
does not reflect increased P2Y2-R number or increased effi-
ciency of P2Y2-R coupling to PLC.
Apical ER Ca2 Stores Are Functionally Increased in CF
Airway Epithelia—We next addressed whether 6–11-day old
monolayers of CF cultures exhibited an increased quantity of
FIG. 1. The larger apical UTP-mobilized Ca2i in CF airway epithelia is not agonist specific. A and B, representative Ca
2
i tracings
depicting the effect of apical UTP-mobilized Ca2i in short term primary culture monolayers of normal and CF human bronchial epithelia,
respectively. C, summary Ca2i values (peak-baseline Ca
2
i) from UTP-stimulated cultures. D and E, representative Ca
2
i tracings depicting the
effect of apical bradykinin (BK)-mobilized Ca2i in short term primary culture monolayers of normal and CF human bronchial epithelia,
respectively. F, compiled Ca2i values (peak-baseline Ca
2
i) from BK-stimulated cultures. Data are expressed as mean  S.E. (n  4 for UTP
studies in both groups; n  3 for BK studies in both groups). *, p  0.05.
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ER Ca2 that could be mobilized in response to IP3 generation
resulting from GPCR activation. To measure the Ca2 storage
capacity of the apical ER, a protocol was developed based on
findings that ER Ca2 stores are functionally confined to the
plasma membrane domain ipsilateral to P2Y2-R activation
(21). 6–11-Day-old normal and CF monolayers, bathed in bi-
lateral nominally Ca2-free buffer, were exposed to 100 M
basolateral UTP to deplete P2Y2-R-sensitive basolateral Ca
2
stores. Basolateral UTP increased Ca2i to the same extent in
both cultures (Fig. 3A), suggesting that basolateral ER Ca2
store capacity was the same in normal and CF epithelia. Apical
ER Ca2 store capacity was then measured with perfusion with
0.6 mM bilateral La3 to block plasma membrane Ca2-AT-
Pases and Ca2 influx channels (22) followed by 1 M apical
thapsigargin (an ER Ca2-ATPase inhibitor) to release Ca2
from apical ER stores (23). Ca2i rose and was sustained be-
cause of inhibition of the plasma membrane and ER Ca2-
ATPases by La3 and thapsigargin, respectively (Fig. 3A). The
greater rise in Ca2i in CF (Fig. 3A) indicated that the quantity
of Ca2 sequestered in the apical ER was functionally greater
in CF compared with normal bronchial epithelial cultures. Fig.
3B illustrates the summary Ca2i data from these experi-
ments. These results led us to speculate that the density of
apical ER Ca2 stores is increased in short term 6–11-day-old
cultures of CF airway epithelia.
Apical ER Ca2 Stores Are Morphologically Expanded in
Short Term CF Airway Epithelial Cultures and Native CF
Airway Epithelia—We next measured the expression of two ER
Ca2 store markers, IP3Rs and calreticulin (an intraluminal
ER protein involved in Ca2 sequestration), in 6–11-day-old
monolayers of normal and CF bronchial epithelia by confocal
immunofluorescence microscopy (Fig. 4). The relative cellular
distribution of these Ca2 store markers was similar in normal
and CF epithelia (i.e. they localized predominantly toward the
apical pole and the fluorescent signals from calreticulin and
IP3Rs were increased in CF cultures (Fig. 4, A and B)). No
immunostaining of Ca2 store markers was detected when the
primary antibodies were omitted or nonspecific IgGs were used
(data not shown). These data suggest an increased expression
of calreticulin and IP3Rs in CF cultures; however, because the
IP3R antibody used recognizes all IP3R isoforms, it is possible
that the change in IP3R signal may reflect a switch in the
predominance of one isoform versus others rather than a
change in the total amount of all IP3Rs in CF. The increase in
CF calreticulin immunofluorescence was confirmed by calreti-
culin immunoblotting from whole cell lysates of early stage
culture monolayers of normal and CF bronchial epithelia
(Fig. 4C).
The apical ER volume of normal and CF epithelia was also
studied by an antibody-independent method, utilizing
DIOC6(3) fluorescence to stain the ER (17). Fig. 4D illustrates
that DIOC6(3) staining was greater in native CF compared
with normal bronchial airway epithelia. The mean apical fluo-
rescence intensity from the CF group exceeded that of the
normal group by a factor proportional to that observed with
antibody-dependent methods (Fig. 4E).
To test whether the topography and expression levels of the
ER Ca2 stores found in CF versus normal short term primary
culture monolayers mimicked those in vivo, confocal immuno-
fluorescence microscopy studies of IP3Rs and calreticulin were
performed in native normal and CF bronchial epithelia (Fig. 4,
F and G). Similar to our findings in short term primary culture
monolayers (Fig. 4, A and B), ER Ca2 stores were distributed
toward the apical domain of native epithelia, and their expres-
sion was increased in CF (Fig. 4, F and G). Collectively, these
data, coupled with the direct measurement of ER density by
electron microscopy (Fig. 5), strongly suggested that the func-
tional increase in apical ER Ca2 storage detected in CF epi-
thelia (Fig. 3) was because of an increase in the ER volume in
the apical domain.
Is the ER Expansion in CF a Result of Misfolded F508
CFTR or an Acquired Response to Chronic Airway Infection?—
Two approaches were used to address this question. First, we
tested the hypothesis that the ER up-regulation could be linked
to abnormal CFTR folding in the absence of infection/inflam-
mation. We elected to study sweat ducts because they are a
source of non-infected CF epithelium and they exhibit rela-
tively high levels of CFTR expression (24). Fig. 5, A and B,
depict the immunostaining of calreticulin in native sweat ducts
from normal and F508 homozygous CF individuals, respec-
tively. Quantification of calreticulin immunofluorescence re-
vealed that its expression was the same in normal and CF
sweat duct epithelia (Fig. 5C), suggesting that the ER expan-
sion observed in CF airway epithelia was not a consequence of
ER retention of F508 CFTR.
Second, we evaluated whether the ER expansion in CF was
acquired by studying airway epithelia from patients with an
unrelated disease characterized by chronic airways infection,
e.g. PCD (8). We quantified morphometrically the ER density in
freshly isolated nasal scrapes from normal (Fig. 5D), F508
homozygous CF (Fig. 5E), and PCD (Fig. 5F) individuals. ER
density, as depicted by red arrows, was increased in both CF
and PCD compared with normal epithelium (Fig. 5G). Apical
UTP-mobilized Ca2i was also increased 2-fold in short term
primary culture monolayers of PCD compared with normal
bronchial epithelia (data not shown). These data suggest that
FIG. 2. P2Y2-R expression and P2Y2-R-PLC coupling efficiency are similar in normal and CF bronchial epithelial cultures. A,
P2Y2-R steady-state mRNA levels from three different samples from short term primary culture monolayers of normal and CF human bronchial
epithelia. B, P2Y2-R mRNA expression levels (corrected for actin mRNA levels) from the data shown in A (n  3 for both groups). C, UTP-dependent
PLC activity (the sum of IP3 metabolites (Ins-1-P, Ins-2-P, Ins(1,3,4)P3, Ins(1,4,5)P3, Ins(1,3,4,5)P4, and Ins(1,3,4,6)P4) in short term primary
culture monolayers of normal and CF human bronchial epithelia. Inositol phosphate levels were normalized to IP6 and expressed as -fold increase
over the inositol phosphate values in the absence of UTP. Data are expressed as mean  S.E. (n  3 for both groups). CF and normal airway
epithelial cells also showed similar levels of IP3, as well as Ins(3,4,5,6)P4, an inhibitor of Ca
2-activated Cl channels (20) (data not shown).
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the apical ER volume is expanded in CF in response to luminal
airway infection and inflammation.
The ER Expansion Observed in Short Term CF Cultures
Reverts to Normal in CF Epithelia Cultured for Long Term in
the Absence of Luminal Infection—To address directly the pos-
sible relationship between luminal infection/inflammation and
ER expansion in CF airway epithelia, normal and F508 ho-
mozygous CF bronchial epithelia were cultured for long term for
30–40 days, and ER density was investigated by calreticulin
immunofluorescence as described in the studies depicted in Fig.
4A. Fig. 6, A and B, depicts the calreticulin expression in a
normal culture and a F508 homozygous CF culture, respec-
tively, illustrating that apical calreticulin expression was no lon-
ger up-regulated in the long term CF compared with the normal
culture. Fig. 6C shows the summary data for apical calreticulin
staining from long term normal and CF cultures. These findings
demonstrate that the ER expansion observed in short term CF
cultures is lost upon prolonged culturing under sterile conditions.
We next investigated whether the morphological reversal of ER
expression to normal correlated with a functional reversal of
agonist-sensitive Ca2 stores to normal in long term F508 CF
cultures. Fig. 6, D and E, illustrates that activation of apical
P2Y2-Rs with mucosal ATP (100 M) elicited a similar Ca
2
i
mobilization in long term normal and CF cultures, respectively.
Fig. 6F depicts the summary Ca2i data (peak-baseline Ca
2
i
values) from these studies. These data demonstrate that the
characteristic phenotype of short term 6–11-day-old F508 CF
cultures (e.g. apical ER expansion associated with increased ag-
onist-sensitive ER Ca2 stores) reverts to normal after long term
culturing in the absence of luminal infection and is independent
of mutated CFTR.
Can the CF Phenotype, e.g. Increased Density of Apically
Confined ER Ca2 Stores Coupled to Larger Apical P2Y2-R
Activation-dependent Ca2i Signals, Be Transferred to Normal
Airway Epithelia by Prolonged Exposure to Mucopurulent Ma-
terial from CF Airways?—The above findings suggest that the
expanded apical ER phenotype does not depend on ER reten-
tion of F508 CFTR but results from an epithelial adaptation
to the in situ CF airway infectious/inflammatory milieu, and it
is lost in vitro with time in the absence of airway infection.
Based on these findings, we hypothesized that the ER expan-
sion and the consequent up-regulation of functional Ca2
stores could be induced in normal airway epithelia exposed to
an infectious/inflammatory luminal environment. To test this
notion, the luminal surfaces of 30–40-day-old normal bronchial
epithelia were exposed for up to 48 h to either PBS or SMM
harvested from CF airways, and the following parameters were
measured. First, the apical ER compartment, visualized by
calreticulin immunofluorescence, was assessed in PBS- versus
SMM-treated cultures. Fig. 7A illustrates that apical ER den-
sity was increased in SMM- compared with PBS-treated cul-
tures in a time-dependent manner. The compiled data from
these studies are shown in Fig. 7B. SMM-treated short term
cultures of normal epithelia also expressed an increased ER
density (not shown). Second, we tested whether the increased
apical ER expression in SMM-treated cultures resulted in
larger Ca2i signals in response to apical P2Y2-R activation
with 100 M mucosal UTP. UTP-mobilized Ca2i was increased
in cultures pretreated with SMM compared with PBS (Fig. 7C),
mimicking the larger mucosal UTP-dependent Ca2i signals
found in short term primary cultures of CF bronchial airway
epithelia (Fig. 1, A–C). These findings demonstrate that
chronic luminal exposure of normal cultures to SMM repro-
duces the increased ER density and apical GPCR activation-
dependent Ca2i signals observed in short term cultures of CF
airway epithelia.
DISCUSSION
We have hypothesized previously that an increased Ca2i
signal coupled to Cl secretion would provide a compensatory
mechanism to offset the absent cAMP-mediated Cl transport
in CF (3). Perhaps the strongest evidence for the role of Ca2i-
mediated Cl secretion in protecting against CF lung disease
came from CF knock-out mice, which express a large endoge-
nous Ca2-activated Cl conductance in the airway epithelia
and are devoid of airway disease (13, 25). CF patients do
exhibit larger Ca2i-dependent responses triggered by luminal
purinoceptor agonists (9, 10), but the mechanism(s) of this
response in human airways has remained unclear.
In this study, we have elucidated the mechanism for the
increased apical GPCR activation-dependent Ca2i signals in
CF human airway epithelia (4) (Fig. 1) by showing that it
resulted from the expansion of the apical ER/Ca2 store com-
partment (Figs. 3–5 and 7) rather than from a greater number
of P2Y2-Rs or coupling efficiency between P2Y2-R activation
and PLC activity (Fig. 2). Although it is plausible that the
higher Ca2i-dependent Cl
 secretion in human CF airway
epithelia may in part be a consequence of an increased Ca2-
activated Cl channel (CaCC) number, our data demonstrating
higher Ca2i mobilization in CF compared with normal human
nasal (4) or bronchial (Fig. 1) epithelia suggest that higher
Ca2i levels at the vicinity of the apical membrane CaCC likely
mediate this response.
A number of observations led to the conclusion that the
enlarged ER in CF reflected an acquired epithelial response to
luminal airway infection/inflammation rather than an ER
stress response to misfolded F508 CFTR (26). First, non-
infected native sweat duct epithelia from F508 homozygous
FIG. 3. The increased Ca2i mobilization triggered by apical purinergic receptor activation in CF airway epithelia reflects larger
apically confined functional ER Ca2 stores. A, representative Ca2i tracings depicting the Ca
2
i responses to sequential exposure of
basolateral UTP (to assess the capacity of UTP-releasable basolateral ER Ca2 stores), bilateral (BL) La3, and apical thapsigargin (TG) (to assess
the capacity of apically confined ER Ca2 stores) in short term primary culture monolayers of normal and CF human bronchial epithelia. Cultures
were bilaterally perfused with a nominally Ca2-free buffer throughout the entire experiment. B, compiled Ca2i values (steady state-baseline
Ca2i) from the experiments shown in A (n  4). Data are expressed as mean  S.E.; *, p  0.05, CF versus normal cultures.
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CF patients exhibited normal ER size (Fig. 5). Second, the
apical ER density was similarly increased in native CF and
PCD airway epithelia (Fig. 5). Third, the expanded ER pheno-
type observed in short term (6–11-day-old, Fig. 4) primary
cultures of F508 CF airway epithelia reverted to normal in
long term (30–40-day-old, Fig. 6) F508 CF cultures. Fourth,
chronic in vitro exposure of normal airway epithelia to bacterial
and inflammatory factors (such as SMM) harvested from CF
airways increased the ER size and Ca2 storage (Fig. 7), mim-
icking the phenotype of short term CF cultures. These data
suggest that the elaborated apical ER phenotype observed in
short term primary cultures of CF airway epithelia, which
mimics that of native CF airway epithelia, 1) reflects a “mem-
ory” of the in situ infectious environment of CF airways, 2)
reverts in vitro in the absence of luminal airway infection, and
3) is independent of the intrinsic F508 CFTR defect.
Regarding host defense mechanisms that clear airway sur-
faces, the raised Ca2i release due to ER expansion, especially
confined to the apical domain (4), (27), may provide an adaptive
response for both the normal and the CF airways. The higher
Ca2i mobilization may be particularly useful to CF patients,
who depend solely on CaCC to compensate for the absent
cAMP-mediated Cl secretion in CF (3). Thus, the approximate
doubling of Ca2i mobilization in CF is predicted to double the
magnitude of Cl secretion (4). This relatively larger compo-
nent of Cl secretion may allow CF airways to transiently
restore defective mucus clearance. In this scenario, cough
(shear stress)-induced release of ATP/UTP (5) into airway sur-
face liquid would produce larger Ca2i signals via apical
P2Y2-R activation and would more effectively activate CaCC
FIG. 4. Apical ER Ca2 stores are morphologically expanded in CF cultures and native CF tissue. A, XZ confocal scans from short term
primary culture monolayers of normal and CF bronchial airway epithelia immunostained for calreticulin or IP3Rs. Bar, 10 m. B, percent of apical
fluorescence intensity from calreticulin and IP3Rs (normalized to fluorescence intensity values from normal cultures; n  5). C, Western blot for
calreticulin from whole cell lysates (50 g of protein/lane) from short term primary culture monolayers of normal and CF bronchial airway epithelia
(representative from three normal and three CF cultures). D, XY confocal scans from normal and CF sections of native bronchial epithelia stained
with DIOC6(3). E, percent of apical DIOC6(3) fluorescence intensity (normalized to fluorescence intensity values from normal sections; n  5). F,
XY confocal scans from normal and CF sections of native bronchial epithelia immunostained for calreticulin and IP3Rs. Bar, 10 m. G, percent of
apical fluorescence intensity from calreticulin and IP3Rs (normalized to fluorescence intensity values from normal sections; n  5 for calreticulin,
and n  3 for IP3Rs in normal and CF). Data are expressed as mean  S.E.; *, p  0.05, CF versus normal epithelia.
ER Ca2 Stores in CF Airway Epithelia 10207
FIG. 6. Apical ER density and ER
Ca2 storage is the same in normal
and CF airway epithelia cultured for
long term in the absence of luminal
infection. ER density, depicted by calre-
ticulin staining, in 30–40-day-old long
term cultures of normal (A) and CF (B)
bronchial airway epithelia. The apical
surface corresponds to the upper area in
figures. Bar, 10 m. C, compiled data for
calreticulin fluorescence from the apical
domain of normal and CF cultures. D and
E, representative Ca2i tracings depicting
the effect of (100 M) apical ATP-mobi-
lized Ca2i in 30–40-day-old long term
cultures of normal and CF human bron-
chial epithelia, respectively. F, compiled
Ca2i values (peak-baseline Ca
2
i) from
ATP-stimulated cultures. Data are ex-
pressed as mean  S.E. (n  3–5).
FIG. 5. ER density is similar in na-
tive F508 homozygous CF versus
normal sweat duct epithelia but
greater in airway epithelia from na-
tive CF and PCD infected airways. XY
confocal scans of the ER (as depicted by
calreticulin staining) in normal (A) and
F508 homozygous CF (B) native sweat
duct epithelia are shown. Bar, 10 m. C,
compiled ER density data from the apical
epithelial domain of normal and F508
homozygous CF sweat ducts (n  4 and 5
individuals for normal and CF, respec-
tively). Micrographs of the apical region of
normal (D), F508 homozygous CF (E),
and PCD (F) nasal ciliated epithelial cells
are shown. Red and black arrows depict
the ER and the intercellular spaces, re-
spectively (see panels D, E, and F). G,
compiled ER density data from the apical
epithelial domain of the three groups (n 
3–4 individuals). Data are expressed as
mean  S.E.; *, p  0.05, CF or PCD
versus normal epithelia.
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and ciliary beat to transiently restore mucus clearance (28).
Conversely, this adaptive airway epithelial response to chronic
luminal infection/inflammation involving the up-regulation of
apical ER Ca2 stores can have an adverse effect, because the
increased agonist-induced Ca2i mobilization in CF airway epi-
thelia may also play a role in Ca2i-dependent airway inflamma-
tory responses (29). A role for increased ER Ca2 stores has been
raised in the pathogenesis of neurological diseases. For example,
ER expansion has been described in a model for Gaucher disease,
where neuronal cells expressed an increase in ER and ryanodine
receptors and a greater ER-dependent Ca2 release in response
to glutamate or caffeine stimulation (30). Thus, the increased
glutamate-dependent Ca2i signal may be linked with the neu-
ronal toxicity and cell death characteristic of Gaucher disease. In
contrast, most cases of Alzheimer disease are caused by preseni-
lin mutations, and it is thought that ER protein (presenilin)
retention (31) leads to increases in ER size and Ca2 storage
capacity in this disease (32–34).
In conclusion, our findings add to the understanding of the
mechanisms and roles of Ca2i-dependent signal transduction
in airway epithelia by elucidating that 1) ER Ca2 stores are
predominantly distributed toward the apical domain, 2) the
apical ER compartment and its capacity to sequester Ca2 are
increased in CF and PCD airway epithelia, and 3) the expan-
sion of the apical ER network is an adaptive innate epithelial
response to chronic luminal airway infection/inflammation. We
speculate that the up-regulation of the ER/Ca2 stores in CF
may reflect a response that can be generalized to other diseases
characterized by persistent epithelial exposure to an infectious
and inflammatory milieu. These observations may prove im-
portant in designing strategies and selecting dosages of thera-
peutic agents aimed at restoring mucus clearance in patients
with chronic infectious lung disease (e.g. CF and PCD) via
regulation of Ca2i-dependent mechanisms.
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FIG. 7. The CF phenotype, e.g. increased density of apically confined ER Ca2 stores coupled to larger apical P2Y2-R activation-
dependent Ca2i signals, is transferred to normal airway epithelia by prolonged mucosal exposure to CF airways mucopurulent
material. A, time course illustrating the ER expansion, depicted by calreticulin staining, in 30–40-day-old normal airway epithelia exposed to
mucosal supernatant from CF airways mucopurulent material over 48 h. Arrows point to the apical surface. Bar, 10 m. B, compiled data for ER
density from the apical domain of PBS- or SMM-treated cultures. C, effect of a 48-h SMM treatment of 30–40-day-old normal cultures of human
bronchial airway epithelia on apical UTP-mobilized Ca2i (340/380 signal from fura-2). Data are expressed as mean  S.E. (n  3; *, p  0.05).
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